Studies have demonstrated that TAMs, particularly those expressing CD163, can physically impede CD8+ T cells from reaching tumor cells and penetrating the tumor parenchyma, thereby limiting their movement and effectiveness within the tumor stroma. Here, CD8A is linked to neoplasm.